In the bustling landscape of India's retail body care market, where fragrance and moisturization take center stage, a transformative innovation is shaking up the norms. Sanfe, an IIT Delhi startup, founded by Archit Agarwal and Harry Sehrawat, has unveiled a groundbreaking solution that goes beyond the conventional offerings. The introduction of Glycoclear Technology is set to redefine the narrative of feminine care, targeting a myriad of complex body care issues faced by Indian women.
Inspiration struck Agarwal and Sehrawat when they observed a lack of confidence in their female colleagues at a farewell party, stemming from concerns like tanned skin, dark underarms, and strawberry skin. In response, these IIT incubated entrepreneurs dedicated months to research, resulting in the development of the revolutionary Glycoclear Technology.
At the heart of this innovation lies the Glycoclear Complex, blending alpha-hydroxy acids (AHAs) and beta-hydroxy acids (BHAs). This breakthrough skincare solution boasts a low pH, ensuring immediate exfoliation from the first use. Its accelerated penetration of actives makes it three times quicker in action, delivering instant nourishment for smoother skin.
"Our mission is to empower women with more than just products. With this technological innovation, Sanfe is aiming to address a broader spectrum of women's body needs," shared Archit Agarwal, Co-Founder of Sanfe.
Harry Sehrawat, Co-Founder of Sanfe, emphasized, "Glycoclear is more than just a skincare solution; it's about breaking free from body concerns and societal norms. Each product is designed not just for effectively solving skin concerns but to instill confidence and liberation in every woman."
Preeti Ranjan Panda, Dean of Corporate Affairs Relations at IIT Delhi said, "I am delighted to witness the groundbreaking innovation of the GlycoClear Complex, a precision AHA and BHA skincare solution developed by the brilliant minds at a Startup of IIT Delhi graduates."
Sanfe proudly announces the trademark granted to Glycoclear Technology, solidifying its position as a pioneer in skincare innovation. The focus on academic excellence underscores Sanfe's commitment to challenging traditional beauty standards.
As Sanfe propels into a new era of skincare, the Glycoclear Technology range comprises 18 products, each dermatologist-approved and subjected to rigorous skin safety tests. From addressing keratosis pilaris to targeting skin discoloration, every product reflects Sanfe's dedication to providing specialized solutions tailored to boost women's confidence and well-being.
Financial Commitment and Growth Projection
Sanfe's dedication to innovation is evident in its financial commitment, boasting an audited turnover of Rs 47.5 crore for FY 2022-23, a significant increase from Rs 25.5 crore in FY 2021-22. Allocating 5 percent of its turnover to research and innovation, the company aims for a colossal target of achieving Rs 500 crore in the next three years, representing a remarkable 500 percent growth in 2-3 years.
Through various funding rounds, Sanfe has raised an impressive $3.93 Ml, with the last Series A round held on April 15, 2022, bringing in $1.5M. With distribution channels spanning online platforms, dermatologists, and salons, Sanfe has achieved an impressive annual revenue run rate of Rs 100 crore, solidifying its position as a major player in the beauty and wellness sector.
In the realm of Indian retail, Sanfe's Glycoclear Technology emerges not just as a skincare solution but as a testament to innovation, commitment, and a bold step towards redefining beauty standards.